Stephen Berenson's Insider Trades & SAST Disclosures
Stephen Berenson's most recent trade in Seres Therapeutics Inc was a trade of 114,782 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen Berenson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seres Therapeutics Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 114,782 | 114,782 | - | - | Stock Option (Right to Buy) | |
| Seres Therapeutics Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 4,601 | 4,601 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 732 | 732 | - | - | Restricted Stock Units | |
| Moderna Inc | Stephen Berenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 670 | 21,471 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Stephen Berenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 670 | 0 | - | - | Restricted Stock Units | |
| Seres Therapeutics Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Moderna Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 4,061 | 4,061 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Stephen Berenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 703 | 20,801 (0%) | 0% | 0 | Common Stock | |
| Moderna Inc | Stephen Berenson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 703 | 0 | - | - | Restricted Stock Units | |
| Moderna Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 670 | 670 | - | - | Restricted Stock Units | |
| Moderna Inc | Stephen Berenson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Aug 2021 | 2,700 | 20,098 (0%) | 0% | - | Common Stock | |
| Moderna Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 4,081 | 4,081 | - | - | Stock Option (Right to Buy) | |
| Moderna Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 703 | 703 | - | - | Restricted Stock Units | |
| Seres Therapeutics Inc | Stephen Berenson | Director | Other type of transaction at price $ 0.00 per share. | 23 Nov 2020 | 3,589 | 3,589 (0%) | 0% | 0 | Common Stock | |
| Seres Therapeutics Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Moderna Inc | Stephen Berenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2020 | 18,270 | 18,270 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges